Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics
Ainsley Mike Antao, Apoorvi Tyagi, Kye-Seong Kim, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1579-1579
Open Access | Times Cited: 113

Showing 1-25 of 113 citing articles:

The role of ubiquitination and deubiquitination in cancer metabolism
Tianshui Sun, Zhuonan Liu, Qing Yang
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 331
Ubiquitin–proteasome system (UPS) as a target for anticancer treatment
Jin‐Young Park, Jinhong Cho, Eun Joo Song
Archives of Pharmacal Research (2020) Vol. 43, Iss. 11, pp. 1144-1161
Open Access | Times Cited: 285
Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches
Fangfang Liu, Jingyu Chen, Kai Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 41
Ubiquitin and Ubiquitin-like Proteins in Cancer, Neurodegenerative Disorders, and Heart Diseases
Jin‐Taek Hwang, Ah Young Lee, Changwon Kho
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5053-5053
Open Access | Times Cited: 43
Post-translational modifications on the retinoblastoma protein
Linbin Zhou, Danny Siu‐Chun Ng, Jason C. Yam, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 40
Targeting Myc-driven stress addiction in colorectal cancer
Haris Saeed, Brian J. Leibowitz, Lin Zhang, et al.
Drug Resistance Updates (2023) Vol. 69, pp. 100963-100963
Open Access | Times Cited: 23
Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways
Rong Wang, Shiwei He, Jun Long, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Exploring Ubiquitin-Specific Proteases as Therapeutic Targets in Glioblastoma
Vijaya Paul Samuel, Ehssan Moglad, Muhammad Afzal, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155443-155443
Closed Access | Times Cited: 9
Deubiquitinase Ubiquitin‐Specific Protease 29 Ameliorates Pathological Cardiac Hypertrophy through Inhibiting Transforming Growth Factor β‐Activated Kinase 1
Xi Jiang, Yan Sun, Hongjie Shi, et al.
Journal of the American Heart Association (2025)
Open Access | Times Cited: 1
Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2
Tianshui Sun, Zhuonan Liu, Fangfang Bi, et al.
Molecular Oncology (2021) Vol. 15, Iss. 12, pp. 3639-3658
Open Access | Times Cited: 50
The Next Frontier: Translational Development of Ubiquitination, SUMOylation, and NEDDylation in Cancer
Nicole E. Pellegrino, Arcan Güven, Kayleigh Gray, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3480-3480
Open Access | Times Cited: 38
Atypical Ubiquitination and Parkinson’s Disease
О.А. Бунеева, A. E. Medvedev
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3705-3705
Open Access | Times Cited: 35
Integrating multi-omics data reveals function and therapeutic potential of deubiquitinating enzymes
Laura M. Doherty, Caitlin E. Mills, Sarah A. Boswell, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 34
Ubiquitination regulation of aerobic glycolysis in cancer
Yao Xie, Mu Wang, Min Xia, et al.
Life Sciences (2022) Vol. 292, pp. 120322-120322
Closed Access | Times Cited: 31
Interaction of ncRNA and Epigenetic Modifications in Gastric Cancer: Focus on Histone Modification
Qingfan Yang, Yu Chen, Rui Guo, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 30
Deubiquitinase OTUD6A promotes breast cancer progression by increasing TopBP1 stability and rendering tumor cells resistant to DNA-damaging therapy
Yan Zhao, Xinping Huang, Dan Zhu, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 12, pp. 2531-2544
Open Access | Times Cited: 29
The ubiquitin-proteasome system in the regulation of tumor dormancy and recurrence
Bashar A. Alhasan, А. В. Морозов, Irina V. Guzhova, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 4, pp. 189119-189119
Closed Access | Times Cited: 7
The role of ubiquitination in health and disease
Yan Liao, Wangzheqi Zhang, Yang Liu, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 7
Deubiquitinase USP5 promotes non-small cell lung cancer cell proliferation by stabilizing cyclin D1
Zhiwei Zhang, Zihan Cui, Zhuolin Xie, et al.
Translational Lung Cancer Research (2021) Vol. 10, Iss. 10, pp. 3995-4011
Open Access | Times Cited: 38
Modulating the Ubiquitin–Proteasome System: A Therapeutic Strategy for Autoimmune Diseases
Dhananjay Yadav, Ji Yeon Lee, Nidhi Puranik, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1093-1093
Open Access | Times Cited: 25
CRISPR/Cas9-based genome-wide screening for deubiquitinase subfamily identifies USP1 regulating MAST1-driven cisplatin-resistance in cancer cells
Apoorvi Tyagi, Kamini Kaushal, Arun Pandian Chandrasekaran, et al.
Theranostics (2022) Vol. 12, Iss. 13, pp. 5949-5970
Open Access | Times Cited: 23
De-ubiquitination of SAMHD1 by USP7 promotes DNA damage repair to overcome oncogenic stress and affect chemotherapy sensitivity
Jingwei Liu, Tingting Zhou, Xiang Da Dong, et al.
Oncogene (2023) Vol. 42, Iss. 22, pp. 1843-1856
Open Access | Times Cited: 16
MiR-21-5p promotes sorafenib resistance and hepatocellular carcinoma progression by regulating SIRT7 ubiquitination through USP24
Zongqiang Hu, Yingpeng Zhao, Yuanyi Mang, et al.
Life Sciences (2023) Vol. 325, pp. 121773-121773
Open Access | Times Cited: 15
The USP10/13 inhibitor, spautin-1, attenuates the progression of glioblastoma by independently regulating RAF-ERK mediated glycolysis and SKP2.
Swathi V. Kona, Shasi V. Kalivendi
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 7, pp. 167291-167291
Closed Access | Times Cited: 5
MDM2/X Inhibitors as Radiosensitizers for Glioblastoma Targeted Therapy
Xanthene Miles, Charlot Vandevoorde, Alistair Hunter, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top